𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Continuous Erythropoietin Receptor Activator (C.E.R.A.) administered at extended administration intervals corrects anaemia in patients with chronic kidney disease on dialysis: a randomised, multicentre, multiple-dose, phase II study

✍ Scribed by A. L. M. DE FRANCISCO; W. SULOWICZ; M. KLINGER; S. NIEMCZYK; V. VARGEMEZIS; F. METIVIER; F. C. DOUGHERTY; D. OGUEY; ON BEHALF OF THE BA16260 STUDY INVESTIGATORS


Book ID
111308164
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
272 KB
Volume
60
Category
Article
ISSN
1368-5031

No coin nor oath required. For personal study only.